Rakesh Verma

Rakesh serves on Prescient’s Board as a Non-Executive Director. After earning a degree in Veterinary Medicine, he completed his MS in Immunology and his PhD in Immunology and Oncology at Imperial College School of Medicine in London. He was then recruited by the oncology biotechnology firm Antisoma, which specializes in the development of antibody-based therapeutics for oncology. After working in oncology drug development for more than a decade, Rakesh joined Prescient in 2007. His renowned expertise in the development and commercialization of biologics makes him an extremely valuable asset to our oncology, immunology and biosimilar clients.